Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. west of scotland coronary prevention study group. Packard, C. J.; O'Reilly, D. S.; Caslake, M. J.; McMahon, A. D.; Ford, I.; Cooney, J.; Macphee, C. H.; Suckling, K. E.; Krishna, M.; Wilkinson, F. E.; Rumley, A.; and Lowe, G. D. N Engl J Med, 343(16):1148-55, 2000. Journal Article Research Support, Non-U.S. Gov't United states
bibtex   
@Article{Packard_2000_1535,
  author = {Packard, C. J. and O'Reilly, D. S. and Caslake, M. J. and McMahon, A. D. and Ford, I. and Cooney, J. and Macphee, C. H. and Suckling, K. E. and Krishna, M. and Wilkinson, F. E. and Rumley, A. and Lowe, G. D.},
 journal = {N Engl J Med},
 note = {Journal Article Research Support, Non-U.S. Gov't United states},
 number = {16},
 pages = {1148-55},
 title = {Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. west of scotland coronary prevention study group},
 volume = {343},
 year = {2000},
 keywords = {Anticholesteremic, Agents/therapeutic, use, Biological, Markers/blood, C-Reactive, Protein/*analysis, Case-Control, Studies, Cholesterol/blood, Coronary, Disease/*etiology/mortality, Fibrinogen/analysis, Humans, Hypercholesterolemia/*blood/complications/drug, therapy, Inflammation/blood/complications/diagnosis, Leukocyte, Count, Logistic, Models, Male, Middle, Aged, Myocardial, Infarction/etiology, Phospholipases, A/*blood, Pravastatin/therapeutic, use, Risk, Factors, Triglycerides/blood},
 title_with_no_special_chars = {Lipoproteinassociated phospholipase A2 as an independent predictor of coronary heart disease West of Scotland Coronary Prevention Study Group}
}
Downloads: 0